Lilly (LLY.US) slimming pills score a victory in the Indian market, with sales soaring 60% in two months.

According to the Securities Times app, Eli Lilly (LLY.US) stated that its blockbuster drug Mounjaro has received a "positive" response in the Indian market, and emphasized that they are making every effort to meet the demand for this drug in the country with the largest population in the world.